Experience in managing glaucoma filtration surgery complications with oral doxycycline: A case series

Document Type

Article

Publication Date

7-1-2022

Abstract

Purpose: To report the clinical profile and effectiveness of oral doxycycline as a non-invasive treatment for glaucoma filtering surgery complications. Method: Prospective case series. Results: Doxycycline is widely used in treating corneal melts, ocular surface diseases, meibomian gland disease, recurrent epithelial cell erosion, rosacea, and keratitis sicca. This prospective case series highlights the successful treatment of five patients with leaking blebs and conjunctiva erosion from glaucoma filtration surgery with the use of oral doxycycline. There was no adverse event reported in our cases. Conclusions: This study suggests that oral doxycycline may be a feasible non-surgical treatment modality due to its ability to inhibit collagenolysis, restore the Meibomian gland function, thereby stopping breakdown and promote conjunctival tissue healing.

Keywords

Doxycycline, Glaucoma filtration surgery, Hypotony, Bleb leaks, Complication

Divisions

ophthalmplogy

Funders

None

Publication Title

European Journal of Ophthalmology

Volume

32

Issue

4

Publisher

SAGE Publications

Publisher Location

1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

This document is currently not available here.

Share

COinS